Three-Dimensional Amide Proton Transfer MR Imaging of Gliomas: current status and future options
Three-Dimensional Amide Proton Transfer (3D APT) is a unique, contrast-free, brain MR imaging method addressing the need for more confident diagnosis in neuro oncology. 3D APT uses the presence of endogenous cellular proteins to produce an MR signal that directly correlates with cell proliferation, a marker of tumor activity. 3D APT supports medical professionals in differentiating low from high grade gliomas, and tumor progression from treatment effect.
In this webinar Dr Stephane Breil will address:
- What APT is and how APT images are generated by an MRI system
- Current 3D APT clinical applications
- Potential future of 3D APT applications
After the lecture, a 15-minute question and answer session will follow. All participants are welcomed and encouraged to share in the dialogue.
Course information
Speaker
Dr Anna Lerman, MD, Dr Stephane Breil, PhD
Country
Venue
Online
Status
Registration Closed
Registration Fee
Free
Audience
Radiologists, Radiographers
Seats Available
-
Summary
This webinar will be presented in a lecture format with Q&A session at the end.
Following registration via this site, registrants will receive an email with the access details nearer to event date.
Duration: 12:30 pm – 1:30 pm SGT (UTC+8)
Agenda
| 12:25 pm - 12:30 pm | Login to the webinar |
|---|---|
| 12:30 pm - 12:35 pm | Welcome by Anna Lerman |
| 12:35 pm - 01:00 pm | Lecture by Stephane Breil |
| 01:00 pm - 01:15 pm | Q&A and closure |
About speaker
Dr Anna Lerman, MD
Business Marketing Manager, MRI, ASEAN Pacific, Philips
Dr Anna Lerman has previous experience as a radiologist working in the field of General Diagnostic and Cardiac Radiology in leading scientific institution hospitals in Moscow, Russia.
Dr Stephane Breil, PhD
MRI Clinical Specialist, Philips
Dr Stephane Breil attained his PhD in NMR Spectroscopy, from the Paul Sabatier University, Toulouse, France. He has 20 years of experience in MRI Advanced Applications.
